Specify a stock or a cryptocurrency in the search bar to get a summary
Beijing Tiantan Biological Products Corp Ltd
600161Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and consulting of blood products in China. Its products include human albumin; intravenous human immunoglobulin; tetanus human immunoglobulin; rabies patient immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; and human prothrombin complex blood products. The company was founded in 1919 and is headquartered in Beijing, China. Beijing Tiantan Biological Products Co., Ltd. is a subsidiary of China National Biotec Group Company Limited. Address: Courtyard No. 2, Beijing, China, 100024
Analytics
WallStreet Target Price
210.39 CNYP/E ratio
35.4063Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 600161
Dividend Analytics 600161
Dividend growth over 5 years
-57 %Continuous growth
–Payout Ratio 5 years average
12 %Dividend History 600161
Stock Valuation 600161
Financials 600161
Results | 2019 | Dynamics |